GBP-213
Sponsor
RenJi Hospital, Shanghai Jiao Tong University
Trial Name
Early Phase 1 Dose Escalation/Expansion
Start Date
2026-11
Est. Completion
2027-07
Participants
24
Location
Shanghai, China
NCT ID
NCT07891364Mechanism
Undisclosed. Given as a subcutaneous injection; the registry does not name the target.
Detailed article coming soon. See the trial details above for current information.
Disclaimer: This information is for educational purposes only and is not medical advice. Clinical trial information is based on publicly available data from ClinicalTrials.gov and published research. Consult your nephrologist before making treatment decisions.